Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Botox Drug Use Investigation (Spasmodic Dysphonia)

Trial Profile

Botox Drug Use Investigation (Spasmodic Dysphonia)

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 18 Sep 2018

At a glance

  • Drugs Botulinum-Toxin-A (Primary)
  • Indications Dysphonia
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 07 Sep 2018 Status changed from recruiting to active, no longer recruiting.
    • 28 Aug 2018 Status changed from not yet recruiting to recruiting.
    • 04 Jun 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top